International Stem Cell ISCO Estimates

OTC ISCO
$0.35 +0.00 (+0.00%)
At close: Sep 25, 2026 · 4:00 PM EDT
Analyst Estimates

International Stem Cell CORP Annual Revenue Estimates

Periods 4
Next Period 2019
Consensus 10.55 M

Analysts expect International Stem Cell CORP to report revenue of 10.55 M for 2019, against a range of 9.64 M to 11.47 M. The most recent reported year, 2018, came in at 11.09 M, a 1.1% beat against the 10.97 M consensus.

Metric 2017201820192020
Reported (Actual) 7.46 M11.09 M--
High Estimate 7.29 M11.42 M11.47 M12.17 M
Low Estimate 6.40 M10.51 M9.64 M10.66 M
Consensus Estimate 6.85 M10.97 M10.55 M11.41 M
Analyst Estimates

International Stem Cell CORP Annual Earnings Per Share (EPS) Estimates

Periods 4
Next Period 2019
Consensus -0.56

Analysts expect International Stem Cell CORP to report earnings per share of -0.56 for 2019, against a range of -0.61 to -0.51. The most recent reported year, 2018, came in at -0.33 , in line with the -0.33 consensus.

Metric 2017201820192020
Reported (Actual) -1.46-0.33--
High Estimate -0.69-0.30-0.51-1.17
Low Estimate -0.79-0.36-0.61-1.31
Consensus Estimate -0.74-0.33-0.56-1.24

International Stem Cell CORP Estimates API

Pull Wall Street consensus for International Stem Cell CORP (high, low and consensus estimates alongside reported actuals) into your own models and apps with the Business Quant Estimates API. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/estimates?ticker=ISCO&mode=revenue&api_key=YOUR_API_KEY